The association of early postoperative lactate levels with morbidity after elective major abdominal surgery by Velicković, Jelena et al.
72
BOSNIAN JOURNAL OF
BASIC MEDICAL SCIENCES WWW.BJBMS.ORG
INTRODUCTION
The number of major surgeries undertaken worldwide 
is estimated to be hundreds of millions per year [1]. Despite 
the progress in surgical and anesthetic techniques, as well as 
the advancement in perioperative patient care, postoperative 
complications (POCs) remain a leading cause of postopera-
tive morbidity and mortality and a serious economic bur-
den to healthcare system [2,3]. To reduce the morbidity and 
improve short-term and long-term survival of patients, early 
recognition of POCs is crucial [4]. It has been demonstrated 
that the impairment of microvascular blood flow both before 
and after major abdominal surgery results in a higher rate of 
POCs [5]. Furthermore, the effect of major surgery on tissue 
perfusion can be indirectly assessed by measuring lactate lev-
els at the end of surgery [6].
Elevated lactate levels are frequently found in critically ill 
patients and often correlate with the disease severity. Because of 
its prognostic role, lactate has been widely used as a biomarker 
for screening, diagnosis, risk stratification, and monitoring in 
critically ill patients. Moreover, lactate levels can be used for 
outcome prediction and as a surrogate endpoint to guide treat-
ment [7]. The rationale for lactate monitoring in critically ill 
patients is based on the fact that hyperlactatemia is most often 
caused by tissue hypoperfusion and increased anaerobic glycol-
ysis. Elevated lactate might also be due to an increased aerobic 
glycolysis, i.e., pyruvate production is higher than the capacity 
of pyruvate dehydrogenases, which occurs as a response to 
cytokine release, increased circulating catecholamines, or the 
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ABSTRACT
Lactate levels are widely used as an indicator of outcome in critically ill patients. We investigated the prognostic value of postoperative lac-
tate levels for postoperative complications (POCs), mortality and length of hospital stay after elective major abdominal surgery. A  total of 
195  patients were prospectively evaluated. Lactate levels were assessed on admission to the intensive care unit (ICU) [L0], at 4 hours (L4), 
12 hours (L12), and 24 hours (L24) after the operation. Demographic and perioperative clinical data were collected. Patients were monitored for 
complications until discharge or death. Receiver operating characteristic (ROC) curves were used to determine the predictive value of lactate 
levels for postoperative outcomes. The best cut-off lactate values were calculated to differentiate between patients with and without complica-
tions, and outcomes in patients with lactate levels above and below the cut-off thresholds were compared. Univariate and multivariate analyses 
were used to identify variables associated with POCs and mortality. Seventy-six patients developed 184 complications (18 deaths), while 119 
had no complications. Serum lactate levels were higher in patients with complications at all time points compared to those without compli-
cations (p < 0.001). L12 had the highest predictive value for complications (AUROC12 = 0.787; 95% CI: 0.719–0.854; p < 0.001) and mortality 
(AUROC12 = 0.872; 95% CI: 0.794–0.950; p < 0.001). The best L12 cut-off value for complications and mortality was 1.35 mmol/l and 1.85 mmol/l, 
respectively. Multivariate analysis revealed that L12 ≥ 1.35 mmol/l was an independent predictor of postoperative morbidity (OR 2.58; 95% CI 
1.27–5.24, p = 0.001). L24 was predictive of POCs after major abdominal surgery. L12 had the best power to discriminate between patients with 
and without POCs and was associated with a longer hospital stay.
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accumulation of leukocytes at the site of inflammation [7]. 
Whatever the underlying cause, early detection of hyperlactate-
mia has shown to be beneficial, since lactate levels were strongly 
related to the Sequential Organ Failure Assessment (SOFA) 
scores and outcomes in critically ill patients [8,9].
Multiple studies have evaluated the prognostic value of 
lactate in heterogeneous groups of critically ill patients, in 
the intensive care unit (ICU) and emergency department 
settings [10-12]. Most of those studies involved patients with 
sepsis, trauma, shock, or severe respiratory failure. On the 
other hand, data on the significance of lactate monitoring in 
a relatively homogeneous population of patients undergoing 
elective major abdominal surgery is scarce.
The aim of our study was to evaluate the ability of early 
postoperative lactate levels, measured at different time points 
after elective major abdominal surgery, to predict various 
POCs. The secondary objectives were to determine the asso-
ciation of static and dynamic measures of lactate homeostasis 
with in-hospital mortality, length of ICU and hospital stay, and 
duration of mechanical ventilation after abdominal surgery.
MATERIALS AND METHODS
Study design and settings
A prospective, observational cohort study was conducted in 
the period January–May 2015 at the tertiary care teaching hospi-
tal in Belgrade with a semi-closed 14-bed surgical ICU (SICU). 
This is a model of ICU in which an intesivist-led team is directly 
responsible for the patient’s care. In addition, the surgeon who 
admitted and operated the patient makes rounds with the ICU 
team contributing to the patient management. Patients are admit-
ted to the ICU for monitoring and recovery after major abdomi-
nal surgery and for the treatment of POCs when indicated.
The study was approved by the Ethics Committee of the 
School of Medicine, University of Belgrade (reference number 
29/XI-13).
Patient selection
This study enrolled all consecutive adult patients (older 
than 18  years) who underwent major abdominal surgery, 
with the expected length of postoperative ICU stay of at least 
24 hours. Major surgery was defined as a laparotomy with the 
operative time of more than 2 hours. Patients were excluded 
if they had an emergency surgery or if they were reoperated 
within the same hospitalization.
Clinical management, data collection, and 
outcomes
All patients were operated under balanced general anes-
thesia. Anesthetic drugs and techniques, intraoperative 
monitoring, and fluid management were selected at the dis-
cretion of the attending anesthesiologist. The patients were 
transferred to the ICU immediately after the end of surgery. 
On ICU admission, they were monitored and resuscitated to 
achieve predefined hemodynamic goals and the target values 
were as follows: mean arterial pressure (MAP) of 65 mmHg; 
central venous oxygen saturation (ScvO2) of 70%; urine output 
of 0.5–1.0 mL/kg/h; and hematocrit (Hct) of 25%. No specific 
algorithm was used for achieving these hemodynamic goals 
and laboratory values, and the use of intravenous fluids, vaso-
pressors, inotropes, diuretics, antihypertensive drugs and 
packed red blood cells (PRBC) was guided by the assessment 
of the attending intensivist. Lactate levels were not directly 
used to guide patient management at the ICU.
For each patient, the following preoperative data were 
obtained: age, sex, body mass index (BMI), history of diabetes, 
hypertension and heart failure, severe renal or liver disease, 
American Society of Anesthesiologists (ASA) risk score, and 
smoking status. Recorded intraoperative variables were type 
of surgery (esophagogastric, hepatic, pancreaticobiliary, col-
orectal, or other); hemodynamic instability defined as MAP 
<65 mmHg or a decrease in MAP for more than 20% of the 
initial value for a period longer than 30  minutes; significant 
bleeding, defined as one requiring transfusion of PRBC, or 
Hct lower than 25%; use of warming devices, such as warm-
ing blankets or fluid warmers; and duration of surgery from 
the induction of anesthesia until the skin closure. Variables 
assessed during the first 24 hours of ICU stay were: hypo-
tension, defined as MAP <65 mmHg for a period longer than 
30 minutes; use of vasopressors; ScvO2; hyperglycemia, defined 
as blood glucose level >11 mmoL/L; 24 hour-fluid balance; 
urine output; Hct; and the Simplified Acute Physiology Score 
II (SAPS II) determined 24 hours after the ICU admission.
Arterial blood gas values and lactate levels were obtained 
on admission (L0), at 4 (L4), 12 (L12), and 24 (L24) hours after the 
operation. The measurements were performed using a com-
mercial point-of-care blood gas analyzer (Gem Premier 3000 
Instrumentation Laboratory, USA). In addition to these static 
measures, we also determined dynamic indices of lactate 
homeostasis. For each patient, lactate area (LA; mmol×h/L) 
representing cumulative lactate and reflecting the severity and 
duration of hyperlactatemia was calculated using the method 
described by Jansen et al. [8]. We also calculated the difference 
between the L12 and L0 and the L24 and L0 as the measure of 
lactate change at 12 and 24 hours, respectively.
Patients were screened for complications and fol-
lowed up until discharge from the hospital or until death. 
Complications were defined as “any deviation from the ideal 
postoperative course that is not inherent in the procedure 
and does not comprise a failure to cure” [13]. We used the 
European Perioperative Clinical Outcome (EPCO) definitions 
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of perioperative outcome measures, issued by the European 
Society of Anaesthesiology-European Society of Intensive 
Care Medicine (ESA-ESICM) joint taskforce, to define each 
POC [14]. The complications were further divided into cardio-
vascular, respiratory, renal, neurological, infectious (including 
surgical wound infection), metabolic, and surgical (defined as 
complications arising as a direct result of a previous surgery, 
such as bleeding or anastomotic leakage). Secondary out-
comes were the length of hospital stay, duration of mechanical 
ventilation, and duration of ICU stay.
Statistical analysis
Continuous data, analyzed using the Student’s t-test or 
Mann–Whitney U test, were expressed as the mean ± standard 
deviation (SD) or median (interquartile range [IQR]) depend-
ing on normality of data distribution. Normality was tested 
using the Kolmogorov–Smirnov test. Categorical data were 
tested with χ2 and Fisher’s exact test as appropriate. Receiver 
operating characteristic (ROC) curves were constructed to 
evaluate the ability of different lactate levels to predict POCs 
and mortality. The best cut-off lactate values to differentiate 
between patients with and without complications were deter-
mined by the Youden’s index. According to these cut-off val-
ues, the sensitivity, specificity, positive predictive value (PPV), 
and negative predictive value (NPV) were calculated and the 
clinical outcomes of patients with lactate levels above and 
below the thresholds were compared. Factors that showed 
statistically significant results with regard to POCs and mor-
tality in the univariate analysis were entered in a multivari-
ate regression model. Odds ratios (ORs) and corresponding 
95% confidence intervals (CIs) were calculated subsequently. 
Statistical analysis was performed with IBM SPSS Statistics for 
Windows, Version 22.0. (IBM Corp., Armonk, NY). The value 
of p < 0.05 was considered statistically significant.
RESULTS
Patient’s characteristics and outcomes
During the study period, a total of 212  patients were 
admitted to the ICU following major abdominal surgery. 
Out of 212 patients, 17 were excluded from the study due to 
the following reasons: 6 were admitted after an emergency 
surgery, 3 underwent reoperation, and in 8  patients there 
was a protocol violation and missing lactate values at more 
than one time point. Finally, 195 patients were evaluated for 
the purpose of this study, of whom 76 (38.97%) developed a 
total of 184 complications, including death in 18 patients. The 
remaining 119 patients had no complications. Characteristics 
of patients with and without complications are summarized 
in Table 1.
The predefined hemodynamic goals and laboratory 
parameters (i.e.,  ScvO2 >70%, MAP >65  mmHg, urine out-
put 0.5–1.0  mL/kg/h, and Hct >25%) were not achieved on 
admission to the ICU in 63/195  patients (32.3%). Among 
these patients, 56/195  (28.6%) had ScvO2 <70%; 14  (7.18%) had 
Hct <25%; 6  (3.1%) had a low urine output; and 16  patients 
(8.2%) had MAP <65 mmHg. At 12 hours of the admission, in 
18/195 patients (9.2%) at least one the hemodynamic goals was 
still not achieved, as follows: ScvO2 was low in 10 (5.1%), Hct was 
<25% in 7 (3.6%), urine output was low in 4 (2.1%), and MAP was 
<65 mmHg in 12 patients (6.1%). Nevertheless, the mean ScvO2 
at 12 hours after ICU admission was within the normal range in 
the entire cohort and did not differ between patients with and 
without complications (71.94% vs. 72.33%, p = 0.663).
Compared to patients without complications, patients 
with complications were significantly older, had higher ASA 
and SAPS II scores, were more likely to be treated with vaso-
pressors, and they less frequently received intraoperative 
warming. As expected, patients with complications had a 
longer duration of mechanical ventilation, ICU, and hospital 
stay. The most common complication was infection, 59/76 of 
patients with complications (77.63%). The median duration of 
ICU and hospital stay was 1.0  (1.0–1.8) and 12.0  (12.0–16.0) 
days, respectively.
Lactate levels
The median lactate level on ICU admission (L0) was 
1.70  (1.20–2.70) mmol/L, L4 was 1.90  (1.10–2.90) mmol/L, 
L12 was 1.10  (0.70–1.625) mmol/L, and median L24 was 
1.20 (0.80–1.60) mmol/L. The median LA was 35.0 (24.4–53.0) 
mmol×h/L. Lactate levels were significantly higher in patients 
with complications at all time points, and the same was demon-
strated for the LA [p < 0.001] (Figure 1). However, lactate lev-
els varied significantly between patients (from both groups) in 
relation to the types of surgery they underwent (Figure 2). This 
difference was observed at all time points of lactate measure-
ment (Kruskal–Wallis; p = 0.023, p < 0.001, p < 0.001, and p 
= 0.003 for L0, L4, L12, and L24, respectively). Particularly high 
serum lactate levels were noted in patients who underwent 
pancreaticobiliary surgery, i.e.,  lactate did not reach the ref-
erence level during the entire 24-hour period resulting in the 
highest LA (44.4 mmol×h/L [31.8–86.1]). The difference in lac-
tate levels at 12 hours after the operation (L12-L0) was 0.6 (0.2–
1.3) mmol/L and it did not differ significantly between patients 
with and without complications (0.6 [0.1–1.1] mmol/L vs. 0.6 
[0.2–1.4] mmol/L; p = 0.682). Similarly, the difference in lactate 
levels at 24 hours after the operation (L24-L0) was 0.5 (0.0–1.4) 
mmol/L, without a significant difference between patients 
with and without complications (0.5 [0.0–1.4] mmol/L vs. 0.6 
[0.1–1.8] mmol/L; p = 0.391).
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Predictive value of postoperative lactate levels
ROC curve analysis showed that lactate levels measured 
at 12 hours after the operation had the highest predictive 
ability for overall POCs (the area under the ROC [AUROC] 
0.787; 95% CI 0.719–0.854; p < 0.001; Figure 3A) and postop-
erative in-hospital mortality (0.872; 0.794–0.950; p < 0.001; 
Figure 3B).
L12 had the best discriminative power for the majority 
of POC types, with the highest AUROC for neurological 
(0.829; 0.723–0.935) and cardiovascular complications (0.801; 
0.683–0.920; p = 0.001), as shown in Table 2.
A ROC curve was also used to determine the best cut-off 
value of L12 which could discriminate between patients with 
and without complications. The L12 value of 1.35 mmol/L 
corresponded to the AUROC of 0.796, sensitivity of 72.0%, 
specificity of 60.8%, PPV of 53.5%, and NPV of 76.4% for 
overall complications. Similarly, 1.85 mmol/L was the opti-
mal cut-off L12 value that discriminated between patients 
who survived and those who did not, with AUROC of 0.881, 
TABLE 1. Characteristics of ICU patients with and without complications following major abdominal surgery
Characteristic Total (n=195)
Complications 
(n=76)
No complications 
(n=119) p
Male (%) 132 (67.7) 53 (69.7) 79 (66.4) 0.626
Age (years) 62.2±12.9 65.4±12.3 60.2±12.9 0.005
Cigarette smoker (%) 58 (29.7) 23 (30.3) 35 (29.4) 0.874
BMI 25.4±4.5 25.3±3.9 25.4±4.8 0.905
ASA >2 55 (28.5) 27 (35.5) 28 (23.5) <0.001
Intraoperative warming 92 (47.2) 17 (18.5) 75 (81.5) <0.001
Bleeding 33 (16.9) 15 (19.7) 18 (15.1) 0.437
Hemodynamic instability 77 (39.5) 35 (46.1) 42 (35.3) 0.176
Duration of surgery (minutes) 165.0 (120.0-240.0) 165.0 (120.0–240.0) 165.0 (108.7–300.0) 0.319
ScvO2 12 hours after ICU admission (%) 72.1±7.3 72.3±8.2 71.9±5.0 0.663
Vasopressor 15 (7.7) 14 (18.4) 1 (0.8) <0.001
Hyperglycemia 80 (41.0) 33 (43.4) 47 (39.5) 0.655
Fluid balance (mL/kg) +56.5±35.6 +59.9±36.4 +54.4±35.1 0.298
SAPS II score 28 (26–31) 30 (27–34) 22 (19–26) <0.001
Type of surgery
Esophagogastric 26 (13.3) 14 (18.4) 12 (10.1) 0.095
Hepatic 19 (9.7) 5 (6.6) 14 (11.8) 0.234
Pancreaticobiliary 33 (16.9) 23 (30.3) 10 (8.4) <0.001
Colorectal 96 (49.2) 25 (32.9) 71 (59.7) <0.001
Other 21 (10.9) 9 (11.8) 12 (10.0) 0.729
ICU stay (days) 1.0 (1.0–1.0) 1.0 (1.0–4.0) 1.0 (1.0–1.0) <0.001
Hospital stay (days after operation) 12.0 (8.0–16.0) 15.0 (11.0–19.0) 9.0 (8.0–14.0) <0.001
Mechanical ventilation (hours) 0.0 (0.0–0.0) 0.0 (0.0–5.0) 0.0 (0.0–0.0) 0.003
Data are presented as mean±standard deviation, number (%), or median (IQR). BMI: Body mass index; ASA: American Society of Anesthesiologists; 
S
cv
O
2
: Central venous oxygen saturation; SAPS II: Simplified acute physiology score; ICU: Intensive care unit; IQR: Interquartile range
FIGURE 1. Lactate levels in patients with and without complications following major abdominal surgery. Data are presented as median 
(interquartile range [IQR]). Serum lactate levels were significantly higher in patients with complications at all time points compared to 
those without complications (*p < 0.001).
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sensitivity of 70.6%, specificity of 81.5%, PPV of 32.2%, and 
NPV of 96.6% (Table 3).
Patients whose L12 levels were above the defined cut-off 
value were considered to have a relative hyperlactatemia 
and were compared regarding the main outcomes with the 
patients whose L12 levels were under the threshold. A  sig-
nificantly higher number of patients with relative hyperlac-
tatemia developed complications (55  vs. 21  patients without 
relative hyperlactatemia, p < 0.001). Moreover, the length of 
hospital stay was significantly longer in patients with relative 
hyperlactatemia (14.0 days [8.0–18.0] vs. 10.0 days [8.0–14.0], 
p < 0.001; Table 4).
Factors associated with complications and 
mortality
According to the univariate logistic regression analysis, risk 
factors for complications were as follows: patient age [in years] 
(OR 1.052, 95% CI 1.017–1.089, p = 0.007), history of heart fail-
ure (OR 3.862, 95% CI 1.145–13.052, p = 0.029), ASA >2 (OR 
2.068, 95% CI 1.367–3.128, p = 0.001), L12 ≥1.35 mmol/L (OR 
TABLE 2. Prognostic value of serum lactate for different postoperative complications following major abdominal surgery
Type of complication Number of patients Best predictive lactate value AUC 95% CI p
Cardiovascular 18 L12 0.818 0.698–0.939 0.001
Respiratory 21 L12 0.760 0.645–0.874 <0.001
Neurological 13 L12 0.829 0.723–0.935 <0.001
Infectious 59 L12 0.783 0.712–0.854 <0.001
Renal 17 L12 0.786 0.682–0.889 <0.001
Surgical 44 L24 0.809 0.733–0.884 <0.000
Metabolic 12 L12 0.802 0.724–0.873 <0.001
AUC: Area under the curve; 95% CI: 95% confidence interval; L12: Lactate levels 12 hours postoperatively; L24: Lactate levels 24 hours postoperatively
TABLE 3. Prognostic value of L
12
 for complications and mortality following major abdominal surgery
Variable Cut-off value (mmol/L) AUC (95% CI) Sensitivity (%) Specificity (%) PPV (%) NPV (%)
L12 for complications 1.35 0.796 (0.688–0.815) 72.0 60.8 53.5 76.4
L12 for mortality 1.85 0.881 (0.779–0.901) 70.6 81.5 32.2 96.6
PPV: Positive predictive value; NPV: Negative predictive value; AUC: Area under the curve; 95% CI: 95% confidence interval; L
12
: Lactate levels 12 hours 
postoperatively
TABLE 4. Outcomes of ICU patients with and without relative hyperlactatemia following major abdominal surgery
Outcome L12≥1.35 mmol/L L12≤1.35 mmol/L p
Complications, n 55 21 <0.001a
Duration of mechanical ventilation (hours) 19.2 (10.1–27.2) 15.6 (8.3–26.5) 0.696b
Length of ICU stay (days) 2.4 (1.0–3.9) 1.6 (0.8–3.3) 0.052b
Length of hospital stay (days) 14.0 (10.0–18.0) 10.0 (8.0–14.0) <0.001b
Data are expressed as median (IQR). n: number of patients; aχ2 test; bMann–Whitney U test; ICU: Intensive care unit; L
12
: Lactate levels 12 hours postoper-
atively; IQR: Interquartile range
FIGURE 2. Serum lactate levels during the first 24 postoperative hours in relation to different types of major abdominal surgery.
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3.720, 95% CI 1.989–6.960, p < 0.001), pancreatic surgery (OR 
4.730, 95% CI 2.101–10.651, p < 0.001), colorectal surgery (OR 
0.331, 95% CI 0.181–0.605, p < 0.001), not receiving intraop-
erative warming (OR 1.862, 95% CI 1.035–2.997, p = 0.008), 
and SAPS II score (OR 3.445, 95% CI 1.244–9.752, p < 0.001). 
Multivariate logistic regression analysis revealed that L12 ≥1.35 
mmol/L was an independent predictor of POCs (OR 2.58; 95% 
CI 1.27–5.24, p = 0.001), along with the SAPS II score [OR 2.05; 
95% CI 1.35–6.04, p < 0.001] (Тable 5).
Variables independently associated with mortality 
were ASA >2 (OR 3.41; 95% CI 1.06–10.94, p < 0.001), L12 
>1.85  mmol/L (OR 3.82; 95% CI 2.46–5.91, p < 0.001), and 
patient age (OR 1.05; 95% CI 1.02–1.09, p = 0.004).
DISCUSSION
Lactate levels are often elevated in critically ill patients 
and can be used as an indicator of clinical outcome. In this 
study, higher serum lactate levels in the early postoperative 
period after the elective major abdominal surgery were asso-
ciated with an increased risk of POCs and mortality. Higher 
lactate was also associated with a longer duration of hospi-
tal stay, despite similar postoperative care in all patients. We 
demonstrated that the lactate levels assessed at 12 hours fol-
lowing the operation had the highest predictive value of the 
adverse outcomes. The cut-off L12 value for complications was 
1.35 mmol/L and for mortality 1.85 mmol/L, both values are 
commonly considered to be within the normal range in criti-
cally ill patients.
Hyperlactatemia following major surgery has been 
observed in many studies [15-19]. It is usually attributed to an 
oxygen debt, resulting from a tissue hypoxia [20]. However, 
there are a number of other causes of hyperlactatemia, and 
some of them, such as the derangement of glucose metabolism 
and the effect of circulating catecholamines, may play a vital role 
during and after a major surgery [21]. A recent study showed 
TABLE  5. Factors associated with postoperative complications following major abdominal surgery according to univariate and 
multivariate regression analysis
Variable
Univariate Multivariate
OR (95% CI) p OR (95% CI) p
Age (years) 1.05 (1.02–1.09) 0.007 1.04 (0.88–1.06) 0.082
History of heart failure 3.86 (1.14–13.05) 0.029 2.43 (0.55–10.69) 0.240
ASA >2 2.07 (1.37–3.13) 0.001 0.91 (0.52–1.59) 0.730
L12 ≥1.35 mmol/L 3.72 (1.99–6.96) <0.001 2.58 (1.27–5.24) 0.001
Pancreatic surgery 4.73 (2.10–10.65) <0.001 2.19 (0.83–5.83) 0.115
Colorectal surgery 0.33 (0.18–0.60) <0.001 0.39 (0.18–0.86) 0.061
Lack of intraoperative warming 1.86 (1.03–2.99) 0.008 1.23 (0.65–2.36) 0.542
SAPS II score 3.44 (1.24–9.75) <0.001 2.05 (1.35–6.04) <0.001
ASA: American Society of Anesthesiologists risk score; SAPS II: Simplified Acute Physiology Score II; L
12
: Lactate levels 12 hours postoperatively; OR: Odds 
ratio; 95% CI: 95% confidence interval
FIGURE 3. ROC curves of serum lactate levels at four time points following major abdominal surgery and lactate area (LA) to pre-
dict postoperative complications (A) and mortality (B). AUC for L
12
 was the highest both for complications (0.722; 95% CI 0.647–0.798; 
p < 0.001) and mortality (0.821; 0.706–0.937; p < 0.001). ROC: Receiver operating characteristic; AUC: Area under the curve; L
12
: Lactate 
levels 12 hours postoperatively; CI: Confidence interval.
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that microcirculatory changes following major abdominal sur-
gery appear to be insignificant and not associated with lactate 
levels or clinical outcomes [22]. However, abdominal surgery 
can be accompanied by an increased surgical stress; therefore, it 
is not surprising that we observed postoperative hyperlactate-
mia regardless of the surgical site. The study by Xiaojuan et al. 
indicated the significant effect of the site of gastrointestinal sur-
gery on postoperative lactate levels [23]. Similar to our results, 
they found the lowest rate of hyperlactatemia after colorectal 
surgery. Although not directly investigated in our study, we can 
assume that an elective colorectal surgery, routinely performed 
and with many available perioperative fast-track protocols, is 
associated with a lower surgical stress compared to a complex 
pancreaticobiliary surgery (which caused the highest postoper-
ative lactate levels according to our results).
Creagh-Brown et al. [24] evaluated the effect of the peak 
serum lactate, in the first 24 hours of ICU admission after 
major gastrointestinal surgery, in a very large cohort of more 
than a hundred thousand patients from 249 hospitals in the 
United Kingdom. They found that increased in-hospital mor-
tality was associated with elevated lactate levels, with no differ-
ence between elective and emergency surgery. Moreover, the 
positive linear relationship between the lactate levels and risk 
of mortality continued down into the normal range of lactate 
(<2 mmol/L). However, due to the retrospective design of their 
study, the authors took into account only the peak lactate level 
during the first 24 hours following ICU admission, which may 
not accurately reflect the clinical outcomes observed in that 
period. Generally, in-hospital mortality as an outcome is a rel-
atively rare event after elective surgeries and only a crude indi-
cator of the quality of care. In the current study, we determined 
that lactate levels measured at 12 hours after an elective major 
abdominal surgery have the best predictive value for both, 
complications and mortality. Consistently, similar results were 
obtained when the analysis was restricted to different types of 
complications. Our results also indicated the importance of 
monitoring lactate trend over time as a predictor of postop-
erative outcomes. However, we found no association between 
the lactate clearance within 12 and 24 hours after the ICU 
admission and the overall complication rate. This may be due 
to the fact that there was no significant difference in the lactate 
clearance between the observed time points. These results are 
in agreement with other studies, suggesting that the duration 
of hyperlactatemia, rather than its extent, is associated with 
poor outcomes in critically ill patients following major surgery 
[25,26]. Meregalli et al. [27] found that lactate levels measured 
12 hours after ICU admission could discriminate between sur-
vivors and nonsurvivors in a group of high-risk, hemodynam-
ically stable, surgical patients [27]. Moreover, persistent hyper-
lactatemia in the nonsurvivors at 48 hours correlated with a 
poor clinical outcome. The authors attributed these findings 
to a continuous and inadequate resuscitation that resulted in 
occult hypoperfusion. The assumption that hyperlactatemia 
results from oxygen debt is the ground for “lactate-guided” 
resuscitation protocols. However, not all studies showed good 
results with these protocols [28,29]. Postoperative hyperlac-
tatemia can be due to different etiologies and measures that 
only target tissue hypoxia to resolve hyperlactatemia may yield 
unsatisfactory results. For example, hyperlactatemia that arises 
in response to an increased surgical stress, postoperative pain, 
or hypothermia is unlikely to be resolved by an increased oxy-
gen delivery. Whatever the underlying cause, elevated serum 
lactate levels on ICU admission following surgery should 
prompt clinicians to analyze all the possible etiologies and 
undertake various measures to control hyperlactatemia early, 
preferably in the first half of day. Although not directly inves-
tigated, we assume that failure of pain control and persistent 
hypothermia during the first 12 hours postoperatively could 
have contributed to the results of our study.
The two cut-off L12 values 1.35 and 1.85 mmol/L, that were 
able to predict morbidity and mortality, respectively in our 
study, are considered to be within the normal range in crit-
ically ill patients. However, a relative hyperlactatemia has 
already been identified as a bad prognostic factor in septic 
patients, suggesting that the serum lactate within the refer-
ence range should be interpreted cautiously [30]. A number of 
studies showed that hyperlactatemia (lactate levels between 2 
and 4 mmol/L) is associated with a worse clinical outcome in 
patients with septic shock. The lower threshold has been pro-
posed according to the new evidence [31]. Since the patients 
undergoing an elective abdominal surgery are considerably 
different compared to septic patients, in our opinion, the 
upper limit of lactate levels associated with worse outcomes 
in this population should be different as well. The results from 
this and other studies indicate the need for re-defining the cut-
off values of serum lactate to predict outcomes in critically ill 
patients in the perioperative setting. Nevertheless, additional 
studies are required to elucidate which of the lactate-guided 
therapies can improve perioperative outcomes. Overall clin-
ical context should be considered when treating postopera-
tive hyperlactatemia. For example, the attempts to normalize 
lactate levels through resuscitation with fluids or inotropes, in 
the absence of other signs of tissue hypoperfusion, may expose 
patients to overhydration and high doses of inotropes with-
out any obvious benefit [29]. Thus, it is important to take into 
account other potential aerobic mechanisms of hyperlactate-
mia and to treat the underlying causes accordingly. With this 
regard, recognition of signs of hepatic dysfunction is essential 
as it is related to lactate clearance. Moreover, reduction of 
increased muscle work arising from shivering, or increased 
work of breathing can decrease serum lactate levels. The 
study by Berg et al. demonstrated that the administration of 
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thiamine may increase the aerobic metabolism in critically ill 
patients with stable hemodynamics, by enabling pyruvate to 
enter the Krebs cycle [32]. However, the role of thiamine in 
decreasing serum lactate and thus affecting the postoperative 
course remains unclear and requires additional studies.
Our study has several limitations. First, it was an observa-
tional study and we did not control for possible confounding fac-
tors, such as the type and quality of anesthesia and surgical tech-
niques, postoperative pain control, and temperature monitoring. 
We also did not use advanced techniques for the estimation of 
tissue perfusion, i.e., monitoring of ScvO2 and microcirculation, 
as these are not routinely used at our ICU. Second, the morbidity 
and mortality were not estimated preoperatively since the fre-
quently used Physiological and Operative Severity Score for the 
enumeration of Mortality and Morbidity (POSSUM) scoring 
system has never been validated in our population. Instead, we 
estimated the effect of patient comorbidities, ASA, and SAPS II 
score on POCs and mortality. Finally, the drawback of our study 
is that we did not collect the data on interventions and therapies 
that could have altered the lactate levels.
The strength of our study is its prospective design and the 
fact that all measurements were done on a single point-of-care 
blood gas analyzer, thus minimizing the variation in read-
ings. Also separate teams of investigators measured lactate 
levels and assessed postoperative outcomes, which probably 
reduced the investigator bias.
CONCLUSION
This study shows that lactate levels during the first 24 hours 
postoperatively have a predictive value for POCs and mortal-
ity after an elective major abdominal surgery. Serum lactate 
levels obtained 12 hours postoperatively had the best predic-
tive value to discriminate between patients with and without 
complications and also between survivors and nonsurvivors. 
Although not explanatory by its design, our study demon-
strates that elevated postoperative lactate is an ominous sign 
that should to be addressed by the intensivist. However, fur-
ther studies are required to indicate which strategies aimed at 
resolving hyperlactatemia improve postoperative outcomes.
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